RxDoctor Payments Data

Robert Cannon, MD

Interventional Pain Medicine · Fayetteville, ARNPI 1104806702

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $13,330 of the $15,271 with a category attached, or 87.3%. AbbVie accounts for 94.0% of it on its own, with 3 other manufacturers making up the rest. Reporting peaked in 2020 at $12,732 and has fallen 98.2% since, to $227 in 2024. Among interventional pain medicine clinicians in AR with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$15,271in general payments, 2019–2025

Across 121 payments — averaging $126.21 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$14K
  • Abbott$712
  • Medtronic$120
  • Pfizer$79

What the payments were for

  • Speaking & faculty fees$13,33087%
  • Travel & lodging$8536%
  • Food & beverage$1,0887%

General payments by program year

19
20
21
22
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AbbVie15$14,359
Abbott94$712
Medtronic(2 entities)8$120
Pfizer4$79

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$15,271 in reported general payments places this provider in the 90th percentile of 29 interventional pain medicine providers in Arkansas.

See all interventional pain medicine providers in Arkansas

Medicare billing

Part B allowed, 2024
$105,287
Medicare patients
270
Services billed
1,399

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Fentanyl24$2,803
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen70$1,589
Tramadol Hcl73$772
Methadone Hcl40$660
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen24$435
Oxycodone Hcl38$397
Gabapentin35$361
Morphine Sulfate ErMorphine Sulfate14$278
Celecoxib18$216
Clonazepam22$129
Pregabalin13$123
Tizanidine Hcl11$106
Baclofen16$105
Diazepam17$28

Paid to pharmacies, not to this prescriber.

Other interventional pain medicine in Fayetteville

See the full list for Arkansas

Where these figures come from

Is this you, or does something look wrong? →